These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7303003)

  • 21. Vibrio cholerae hemagglutinin/protease nicks cholera enterotoxin.
    Booth BA; Boesman-Finkelstein M; Finkelstein RA
    Infect Immun; 1984 Sep; 45(3):558-60. PubMed ID: 6432694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GM(1)-functionalized liposomes in a microtiter plate assay for cholera toxin in Vibrio cholerae culture samples.
    Edwards KA; March JC
    Anal Biochem; 2007 Sep; 368(1):39-48. PubMed ID: 17603995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification, molecular and kinetic characterization of phosphofructokinase-1 from the yeast Schizosaccharomyces pombe: evidence for an unusual subunit composition.
    Reuter R; Naumann M; Bär J; Haferburg D; Kopperschläger G
    Yeast; 2000 Oct; 16(14):1273-85. PubMed ID: 11015725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A- and B-subunit variant distribution in the holoprotein variants of protein toxin abrin: variants of abrins I and III have constant toxic A subunits and variant lectin B subunits.
    Hegde R; Podder SK
    Arch Biochem Biophys; 1997 Aug; 344(1):75-84. PubMed ID: 9244384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification of recombinant shiga-like toxin type I B subunit.
    Austin PR; Hovde CJ
    Protein Expr Purif; 1995 Dec; 6(6):771-9. PubMed ID: 8746629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular genetic features of Vibrio cholerae classica strains, that caused the Asiatic cholera epidemic in Russian in 1942].
    Smirnova NI; Cheldyshova NB; Zadnova SP; Kutyrev VV
    Mol Gen Mikrobiol Virusol; 2001; (4):12-8. PubMed ID: 11816113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of denaturated proteins and biotoxins by on-line size-exclusion chromatography-digestion-liquid chromatography-electrospray mass spectrometry.
    Carol J; Gorseling MC; de Jong CF; Lingeman H; Kientz CE; van Baar BL; Irth H
    Anal Biochem; 2005 Nov; 346(1):150-7. PubMed ID: 16185643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subunit structure and N-terminal amino acid sequence of the three chains of cholera enterotoxin.
    Klapper DG; Finkelstein RA; Capra JD
    Immunochemistry; 1976 Jul; 13(7):605-11. PubMed ID: 955672
    [No Abstract]   [Full Text] [Related]  

  • 30. Cholera toxin and related enterotoxins: a cell biological and immunological perspective.
    de Haan L; Hirst TR
    J Nat Toxins; 2000 Aug; 9(3):281-97. PubMed ID: 10994530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Production of an erythrocytic ganglioside diagnostic reagent for detecting cholera enterotoxin and toxoid in indirect hemagglutination tests].
    Dolmatova LA; Efremenko VI; Narbutovich NI; Vladimtseva IV
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):101-4. PubMed ID: 7331599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical and physical properties of cholera exo-enterotoxin (choleragen) and its spontaneously formed toxoid (choleragenoid).
    Lospalluto JJ; Finkelstein RA
    Biochim Biophys Acta; 1972 Jan; 257(1):158-66. PubMed ID: 5009826
    [No Abstract]   [Full Text] [Related]  

  • 33. Primary structure of the B subunit of cholera enterotoxin.
    Nakashima Y; Napiorkowski P; Schafer DE; Konigsberg WH
    FEBS Lett; 1976 Oct; 68(2):275-8. PubMed ID: 976480
    [No Abstract]   [Full Text] [Related]  

  • 34. Properties of the cholera exo-enterotoxin: effects of dispersing agents and reducing agents in gel filtration and electrophoresis.
    Finkelstein RA; LaRue MK; LoSpalluto JJ
    Infect Immun; 1972 Dec; 6(6):934-44. PubMed ID: 4638498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Origin of the enzymatically active A1 fragment of cholera toxin.
    Gill DM; Rappaport RS
    J Infect Dis; 1979 Jun; 139(6):674-80. PubMed ID: 448194
    [No Abstract]   [Full Text] [Related]  

  • 36. Difference in resistance of subunits A and B of Vibrio cholerae toxin (choleragen) to treatment with pronase.
    Neri P; Antoni G; Tarli P
    Experientia; 1978 Oct; 34(10):1293-4. PubMed ID: 738397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Determination of cholera enterotoxin using the coagglutination reaction].
    Belaia IuA; Gaĭlonskaia IN; Bystrova SM; Ferapontov GK
    Vestn Akad Med Nauk SSSR; 1984; (10):69-73. PubMed ID: 6506856
    [No Abstract]   [Full Text] [Related]  

  • 38. Small-molecular-weight cytotoxic factor in cholera toxin.
    Tyrrell DA; Inwood JE
    Lancet; 1970 Jul; 2(7662):47. PubMed ID: 4193783
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunoserological characteristics of homogeneous choleragen and neuraminidase preparations.
    Vertiev YuV ; Shaginiyan IA; Ezepchuk YuV
    Zentralbl Bakteriol A; 1981; 249(2):235-41. PubMed ID: 7269852
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular properties of cholera enteroxin.
    Okajima Y; Shimamura T; Ozawa A; Sasaki S
    Tokai J Exp Clin Med; 1981 Apr; 6(2):193-201. PubMed ID: 7303003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.